Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00572780 · ClinicalTrials.gov registry record
Can CT Enteroclysis Predict the Outcome of Crohn's Disease
A clinical trial, sponsored by Indiana University.
- Completed
- Registry status
- 125
- Enrollment target
NCT00572780: Completed study, sponsored by Indiana University.
NCT00572780 is a clinical trial that has completed, run by Indiana University. The registered enrollment target is 125 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00572780 has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 125 participants
- Enrollment target
Study Summary
Specific CT Enteroclysis findings with or without other clinical and laboratory variables, can identify Crohn's disease patients who will response to medical therapy versus those who will either fail and require surgery or have uncontrolled disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2007-08 |
| Est. Completion | 2012-01 |
What the finished NCT00572780 record still lists
NCT00572780 is an observational study that tracks outcomes without assigning an intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00572780 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00572780 about?
NCT00572780 is a clinical study titled "Can CT Enteroclysis Predict the Outcome of Crohn's Disease". Specific CT Enteroclysis findings with or without other clinical and laboratory variables, can identify Crohn's disease patients who will response to medical therapy versus those who will either fail and require surgery or have uncontrolled disease.
What is the current status of trial NCT00572780?
This trial is currently completed. The enrollment target is 125 participants. The study started on 2007-08. Estimated completion is 2012-01.
Who is sponsoring clinical trial NCT00572780?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02717039 · 125 participants
Pharmacogenomics of Heparin-Induced Thrombocytopenia
- NCT02763033 · 125 participants · Phase 2
Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients
- NCT02793999 · 125 participants
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
- NCT03003299 · 125 participants · NA
PARTNER 3 Trial - Aortic Valve-in-Valve
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia